Trial Profile
A Prospective, Randomized, Double-Blind, Placebo- and Sham-Controlled, Multicenter, Phase 1b Study of OTO-201 Given as a Single Intratympanic Injection for Intra-Operative Treatment of Middle Ear Effusion in Pediatric Subjects Requiring Tympanostomy Tube Placement
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 14 Jan 2020
Price :
$35
*
At a glance
- Drugs Ciprofloxacin (Primary)
- Indications Otitis media
- Focus Adverse reactions; First in man
- Sponsors Otonomy [CEASED]
- 10 Jun 2011 Planned initiation date changed from 1 Jun 2011 to 1 Dec 2011.
- 23 Feb 2011 New trial record